KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Payables (2016 - 2025)

Petmed Express has reported Payables over the past 15 years, most recently at $20.3 million for Q4 2025.

  • For Q4 2025, Payables rose 85.47% year-over-year to $20.3 million; the TTM value through Dec 2025 reached $20.3 million, up 85.47%, while the annual FY2025 figure was $23.6 million, 36.35% down from the prior year.
  • Payables for Q4 2025 was $20.3 million at Petmed Express, up from $19.1 million in the prior quarter.
  • Over five years, Payables peaked at $40.0 million in Q2 2023 and troughed at $10.9 million in Q4 2024.
  • A 5-year average of $24.6 million and a median of $24.1 million in 2022 define the central range for Payables.
  • Biggest five-year swings in Payables: surged 135.08% in 2023 and later tumbled 71.83% in 2024.
  • Year by year, Payables stood at $21.9 million in 2021, then rose by 10.86% to $24.3 million in 2022, then surged by 59.77% to $38.9 million in 2023, then tumbled by 71.83% to $10.9 million in 2024, then surged by 85.47% to $20.3 million in 2025.
  • Business Quant data shows Payables for PETS at $20.3 million in Q4 2025, $19.1 million in Q3 2025, and $20.0 million in Q2 2025.